Private Wealth Management Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Private Wealth Management Group, LLC
- $301 Billion
- Q2 2025
A detailed history of Private Wealth Management Group, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Private Wealth Management Group, LLC holds 59 shares of REGN stock, worth $32,720. This represents 0.01% of its overall portfolio holdings.
Number of Shares
59
Previous 41
43.9%
Holding current value
$32,720
Previous $26 Million
19.12%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding REGN
# of Institutions
1,445Shares Held
84.8MCall Options Held
1.4MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA9.41MShares$5.22 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.68 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.14 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.66 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.21 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $59.4B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...